Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06398652
Status:
RECRUITING
Last Update Posted:
2024-05-03
First Post:
2024-05-01
Brief Title:
Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque Psoriasis
Sponsor:
Taizhou Mabtech Pharmaceutical CoLtd
Organization:
Taizhou Mabtech Pharmaceutical CoLtd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-01
First Submit QC Date:
May 1 2024
Study First Post Date:
2024-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-12
Last Update Post Date:
2024-05-03
Last Update Post Date Type:
ACTUAL